summary_detistov
TRANSCRIPT
2
FULBRIGHT PROGRAM
In 1945, Senator J. William Fulbright introduced a bill in the United States Congress that called for the use of surplus war property to fund the 'promotion of international good will through the exchange of students in the fields of education, culture, and science.'On August 1, 1946, President Harry S. Truman signed the bill into law, and Congress created the Fulbright Program, the flagship international educational exchange program sponsored by the U.S. Government.
THE FULBRIGHT MISSION STATEMENT
The worldwide Fulbright Program is designed to:• Increase mutual understanding between the people of the United States and the people of other countries.• Strengthen the ties that unite the United States with other nations.• Promote international cooperation for education and cultural advancement.• Assist in the development of friendly, sympathetic, and peaceful relations between the United States and other countries of the world.
3
RESEARCH WORK IN A FIELD OF COMBINATORIAL CHEMISTRY 2003 − 2008 yy
Work was done under general support of and in cooperation with Chemical Diversity company. ChemDiv is a fully integrated contract research organization headquartered in San Diego, California, with subsidiaries in Russia and Ukraine.
4
One-pot liquid-phase parallel synthesis of 1,2,4-oxadiazole libraries by approach A
OH
O
R2 + CDI +NH2
N OH
R1
1 2 3
Subsequent addition of reagents
R: Heteryl;R`: Alkyl, Aryl.
NH2
N O
R1
O
R`DMF
50-60 0C
I-1
N
NO R`
R2
DMF
110 0C
4 - 12
5
Heteryl-1,2,4-oxadiazoles synthesized by approach А
4 (approx. 700 compounds) 5 (approx. 600 compounds) 6 (approx. 300 compounds)
R1: Alkyl, Aryl, Heteryl; R2: Aryl, Heteryl.
R1: Aryl;R2: Aryl, Heteryl.
R1: Aryl, Heteryl. R2: Aryl, Heteryl.
7 (approx. 400 compounds) 8 (approx. 1000 compounds) 9 (approx. 200 compounds)
R1: H, Alkyl, Alkoxy, Halogen;R2: Aryl, Heteryl.
R1: H, Alkyl, Alkoxy, Halogen;R2: Alkyl;R3: Aryl, Heteryl.
R1: H, Alkyl, Alkoxy, Halogen;R2: Alkyl;R3: Aryl, Heteryl;n: 1-3.
10 (approx. 50 compounds) 11 (approx. 50 compounds)
12 (approx. 50 compounds)
R1: Aryl, Heteryl; n = 1-4
R1: Aryl, Heteryl. R1: Aryl, Heteryl. X = N, O
N
NO
R2
N N
R1N
ON
NO
R1
R2N
NO
R2
NS
O
O
R1
N
NOR2
O OR1
N
NO
N
OR3
R2
R1R1
N
NO
R3
N
N
O
O
R2
n
ON
N
N
N
n
R1
N
NO
N
N R1 X
NN
NO
R1
6
In-house methods for synthesis of useful functionalized building-blocks of 1,2,4-oxadiazole row
NH2
N OHR1
1
R1: Aryl, Heteryl.
NN
O
N
N
ON
NR1
14
13
O O
O
N
ON
OR1
15
16
7
NON
NR1
17
R2O
OH
O O
N
NOR1
R2
18: R1 = 4-CH3O-C6H4, 4-CH3-C6H4;R2 = 8-OH, 8-C2H5O;
14O NH
N
NOR1
R2
i-Pr-OH, piperidine
17
R2O
OH
19: R1 = 4-CH3O-C6H4, 4-CH3-C6H4; R2 = H, 8-C2H5O; 4-CH3-C6H4;
NH2
R4
O N
N
NOR2
R4
R1
CH3COOH
20
21
R4 = 4-CH3, 4-CH3CO, 4-CH3CONH.
NH2 OH
O
N
NO
NOH
R2
R1
O
O
O
R6R6
O
N
NO
NO
R2
O
R6
R1
CH3COOH
24
25
26
27
R6 = CH3, C2H5, (CH3)2CH.
SNH
O
ONH2
R5
O N
N
NO
NHS
O
O
R2
R5
R1
CH3COOH
22
23
R5 = 4-CH3, 3,4-di(CH3O), 2,5-di(CH3O).
28
N
O
OH
OH
NO O
N
NOR1
OH
29: R1 = 4-CH3O-C6H4, 4-CH3-C6H4;
H Cl1. MeOH, piperidine2. HCl, H2O
Reactions involving 5-cyanomethyl-1,2,4-oxadiazoles 14
8
NON
NR1
14
NO N
NR1
SS
1. CS2 (30), NaOH2. CH3I (31)
dioxane / H2O
32: R1 = C6H5; 4-CH3-C6H4; 4-CH3O-C6H4; 4-Cl-C6H4.
NO N
NR1
SNH
R2
33: X = N; R1 = C6H5, 4-CH3-C6H4,4-CH3O-C6H4, 4-Cl-C6H4. R2 = CH3, C6H5,C2H5
Method A
R2NH2
i- Pr-OH
34
1. R2NCS (35), NaOH2. CH3I
Method B
dioxane
Reactions involving 5-cyanomethyl-1,2,4-oxadiazoles 14
9
NO N
NR1
SX
R2
33: X = N; R1 = C6H5, 4-CH3-C6H4,4-CH3O-C6H4, 4-Cl-C6H4. R2 = CH3, C6H5,C2H5
NH2 NH2
EtOH O N
NR1
XNN
NH2
R2
36, 37
32: X = S; R1 = C6H5, 4-CH3-C6H4,4-CH3O-C6H4; R2 = CH3.
Reactions involving 5-cyanomethyl-1,2,4-oxadiazoles 14
ClNH
OR3
41
N
NO
NN NH2
X
NH
O
R1
R3
R2
42, 43
NOESY
K2CO3, DMF
42a: R1 = C6H5; 42b-g: R1 = 4-CH3-C6H4; 43a-g: R1 = 4-Cl-C6H4;43a-g: R2 = CH3, C2H5, CH(CH3)2, CH2CHCH2, C6H5.42: R3 = 3-CH3O-C6H4-CH2, 3-Cl-4-CH3-C6H3, 4-C2H5O-C6H4, 4-CH3-C6H4, 3-F-4-CH3-C6H3, 3-Cl-4-F-C6H3, 4-CH3O-C6H4. 43:R3 = 3,5-di-CH3-C6H3, 2-CH3O-5-CH3-C6H3, 3-C2H5-C6H4, 2-Cl-C6H4-CH2, 4-Cl-C6H4-CH2, 2,4,6-three-CH3-C6H2,2,4,6-three-CH3-C6H2.
O
O
O
R6
R5
38
CH3COOH
N
NO
N
X
NNH
O
R1
R2
R5R6
39, 40
36, 39: R1 = 4-CH3-C6H4; 37, 40: R1 = C6H4; R1 = 4-Cl-C6H4; R2 = CH3, CH2CHCH2; R5 = CH3, C2H5; R6 = H, CH3,
10
NON
NR1
14
O
O
MeOH, piperidine
ON
NR1
NH
O
45: R1 = C6H5, 4-CH3O-C6H4, 4-CH3-C6H4,4-Cl-C6H4.
44
Reactions involving 5-cyanomethyl-1,2,4-oxadiazoles 14
O
R2
N
ON
NR1
R2
EtOH, piperidine
47: R1 = 3-CH3-C6H4, 4-(CH3)2CHO-C6H4, 2-C6H4N;R2 = 4-Br-C6H4, 4-(CH3)2N-C6H4, 4-CH3O-C6H4, 4-NO2-C6H4.
N
ON
ONH2
N
NH
R1
R2
N NH
O
CH3CN
49: R1: 3-CH3-C6H4,4-(CH3)2CHO-C6H4, 2-C5H4N.R2: 4-Br-C6H4, 4-(CH3)2N-C6H4,4-CH3O-C6H4.
46
48
N3R2
N
ON
NH2
N
NN
R1
R2
50
51: R1 = C6H5, 4-CH3O-C6H4;R2 = C6H5, 4-CH3-C6H4, 3-CH3O-C6H4, 2-Cl-C6H4, F-C6H4.
MeOH, MeONa
11
N
ON
OR1
14
Reactions involving 5-acetonyl-1,2,4-oxadiazoles 16
N
ON
OR1
EtOH, HClNH2
S
NH2
+ N
ON
R1
NH
NH
S
OH
R1 = C6H5, 2-CH3-C6H4, 4-CH3O-C6H4; R2 = H, 3,4-benzo.
16 17 54 56 57
+O
OH
R2 + R2
N
O
N
R1
O
NH
NH
S
N
ON
N
NN
R1
R2
N3R2
MeOH, MeONa
R1 = 3,4-CH2O2-C6H3, 2-Cl-C6H4;R2 = 3,4-di-(CH3O)-C6H3, 2,5-di-(CH3O)-C6H3, 3-CF3-C6H4, 2,4-di-(F)-C6H3, 4-CH3OOC-C6H4.
52
53
O
R2
EtOH, HCl
NH2
S
NH2
+
N
ON
R1
NH
NH
S
R2
R1 = C6H5, 2-CH3-C6H4, 4-CH3-C6H4, 4-Cl-C6H4; 2-F-C6H4, 3,4-CH2O2-C6H3, 3,4-di-(CH3O)-C6H3; R2 = C6H5, 4-CH3O-C6H4, 4-CH3S-C6H4, 4-(CH3)2N-C6H4;
55 54
56
12
Figure 1 1H NMR spectrum of 5-methyl-13-[3-(2-methylphenyl)-1,2,4-oxadiazol-5-yl]-1,2,4,5-tetrahydro-3H-1,5-methanonaphtho[1,2-g][1,3,5]oxadiazocine-3-thione, 57
13
Figure 2. 13C NMR spectrum of 5-methyl-13-[3-(2-methylphenyl)-1,2,4-oxadiazol-5-yl]-1,2,4,5-tetrahydro-3H-1,5-methanonaphtho[1,2-g][1,3,5]oxadiazocine-3-thione, 57
15
CUSTOM SYNTHESIS OF BUILDING BLOCKS FOR BIOMOLECULAR RESEARCH
2008 − 2009 yy
Work was done under general support of and in cooperation with InterBioScreen. IBS is a Moscow-based joint-stock company providing biologically active natural as well as synthetic organic compounds for screening at pharmaceutical, agrochemical and biotechnology companies.
16
NO
O
R2 O
O+ CDI +
NH2
N OH
R1
1 2 3 58
DMF
110 0C
NO
O
N
NO
R1
R2
1) NH2-NH2, i-Pr-OH2) HCl (gas), benzene
HCl
59
Where,
R1 = Aryl;R2 = Amino acid residue.
N
NO
R1
NH2
R2
Synthetic route for preparation of 5-aminoalkyl-1,2,4-oxadiazoles 59
17
Examples of 5-aminoalkyl-1,2,4-oxadiazoles synthesized by this method
59a 42 g 59b 40 g 59c 50 g
59d 50 g 59e 60 g 59f 40 g
59g 80 g 59h 35 g 59i 50 g
NO
NNH2
O
O
S
N
ON
NH2
N
NONH2 F F
FN
NO
O
F
F
F
NH2N
NO F
FNH2
N
NONH2
ON
NO
NH2
N
NONH2
NN
ONH2
18
CUSTOM SYNTHESIS OF BUILDING BLOCKS FOR BIOMOLECULAR RESEARCH
2010-2011 yy
Princeton BioMolecular Research is a privately held company established in 1998. Field of research work includes design of unique small molecules and development of advanced tools for drug discovery, enabling new generations of chemical entities.
19
Syntheses of commercially unavailable benzofurans and benzothiophenes by modified Stobbe method
X
O +
O
O
O
O
MeOLi
MeOH X
O
O
O
O Li+
O
O O
X
O
O
O
O
1) NaHCO3,
EtOH / H2O
2) H+
X
OH
O
O
Where X = O, S.
60 61 62
64 63
20
Syntheses of commercially unavailable benzofurans and benzothiophenes by modified Stobbe method
X
OH
O
O
R Hal
K2CO3, DMF X
O
O
O
R
X
O
OH
O
R
1) OH-, EtOH / H2O
2) H+
Where X = O, S.
64 65 66
64a 40 g 66a 25 g 66b 25 g 66c 25 g
66c 50 g 66d 30 g 66e 20 g 66f 20 g
O
OH
O
OO
O
OH
OO
O
OH
OO
O
OH
O
O
O
OH
O O
OCHF2
O
O
S
O
OH
O S
O
OH
O
Examples of benzofurans and benzothiophenes synthesized by this method
23
• Conjugated (semiconductive) polymers:
Motivation
n
SS
SS
Rn
R
R
R
Polymer LED Picture from:J. Mater. Chem. 2007, 17, 3551
Color flat-panel displays
Picture from: nature.com (Seiko–Epson Corp)
Polymer solar cells Picture from:
University of Regensburg (Germany)
24
Nanoscale organization can be controlled by polymer’s architecture
Molecular brushes
“Hairy” particlesPlanar brushes
25
mono
Init.
mono
mono
mono
mono
mono
mono
Prerequisite for chain-growth polymerization mechanism:one-by-one addition of monomers to initiator points
36
McCullough-Yokozawa mechanism of Kumada Catalyst Transfer Polycondensation (KCTP)
SClMg
Br
R
2
monomer
catalyst precursor
NiL2Cl2
- MgCl2
NiL2
SS
R R
BrBrS S
R R
Br Br
+Ni(0)L2
"real" Ni(0) catalyst
S S
R R
Br Ni(L2)Br
SClMg
Br
R
- MgBrCl
S
S S
R R
Br Ni(L2)
R
Br
intramolecular transfer
SR
Br
S S
R R
Br
.
Ni(0)L2
SR
NiL2Br
S S
R R
Br
Poly-3-alkylthiophen (P3AT)
SR
H
S S
R R
Br n
37
Commercially available Ni-based initiators and catalysts
Ni
Cl P
Cl P
Ph Ph
Ph Ph
NidpppCl2
[1,3-Bis(diphenylphosphino)propane]nickel(II) chloride
Ni
P
P
Ph
Ph
Ph
Ph
initiators (precursors) catalysts
[1,3-Bis(diphenylphosphino)propane]nickel(0)
Ni
Cl P
Cl P
Ph Ph
Ph Ph
[1,2-Bis(diphenylphosphino)ethane]nickel(II) chloride
Ni
P
P
Ph
Ph
Ph
Ph
[1,2-Bis(diphenylphosphino)ethane]nickel(0)
NidppeCl2
38
Commercially unavailable Ni-based initiators and catalysts
Ni
P
Br P
Ph Ph
Ph Ph
Ph
PhNidpppBr
Phenyl[1,3-Bis(diphenylphosphino)propane]nickel(II) bromide
Ni
P
P
Ph
Ph
Ph
Ph
initiators (precursors) catalysts
[1,3-Bis(diphenylphosphino)propane]nickel(0)
Ni
P
Br P
Ph Ph
Ph Ph
Ph
Phenyl[1,2-Bis(diphenylphosphino)ethane]nickel(II) bromide
Ni
P
P
Ph
Ph
Ph
Ph
[1,2-Bis(diphenylphosphino)ethane]nickel(0)
PhNidppeBr
39
Ligand-exchange strategy
Br
NN
Ni
Et Et NN
Ni
Br
P PPh Ph
Ph Ph
n
PP
Ni
Br
PhPhPh Ph
n
24
Where n = 0,1If n=0, PhNidppeBrIf n=1, PhNidpppBr
S
R
BrBrMgn
Initiated by PhNidppeBr or PhNidpppBr
S
R
Hn
Terminated by H+
40
SiO
O
O
.
.
.
Br
NN
Ni
Et Et
P PPh Ph
Ph Ph
2
4
SiO
O
O
.
.
.N
N
Ni
Br
ligand exchange
SiO
O
O
.
.
.P
P
Ni
Br
Ph
PhPh
Ph
S
R
BrClMgn
Kumada chain-growth polycondensation
SiO
O
O
.
.
.
S
R
Hn
organosilica
40
O
O
OBr
O
O
OBr
surface-initiated polymerization
Si
Si
“hairy” P3ATs particles
Grafting from organosilica
41
Thiophen-based precursors under investigation
S
NN
Br Br
TBP-1 TBP-2
SSBr Br
TBP-3
Si
SSBr Br
TBP-4
O
O
S
SBr Br
S
N
NO
Br Br
TBP-5
*
**
*
*
**
** commercially unavailable
* Provided by Luminescence Technology Corp. http://www.lumtec.com.tw/index.aspPrice - USD 1700 / 5 g
42
Synthesis of TBP-1
Br2
MgMgBr2
1) CuBr, LiBr
Cl
O
O
Cl2)
O
O
14 + 16
S
NN
TBP-1
S
NH3
+NH3
+ClCl
K2CO3
S
NH2NH2
NBS
DMF
S
NN
BrBr
Yield = 52 %
Yield = 38 %
Yield = 82 %
Yield = 65 %
Step 1
Step 2
Step 3 Step 4
43
1H NMR spectrum of TBP-1
8 7 6 5 4 3 2 1 0Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Inte
ns
ity
15.97 12.003.43 1.79
Chloroform-d
N
N
S
CH3
CH3
CH3
CH3
Br
Br
44
13C NMR spectrum of TBP-1
160 140 120 100 80 60 40 20 0Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Inte
ns
ity
Chloroform-d
11.2
01
4.3
4
23
.25
26
.37
29
.12
33
.07
38
.20
39
.77
10
3.4
1
13
9.3
7
15
8.1
3
S
N N
CH3 CH3
BrBr
CH3 CH3
45
8 7 6 5 4 3 2 1 0Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Inte
ns
ity
15.97 12.003.43 1.79
Chloroform-d
N
N
S
CH3
CH3
CH3
CH3
Br
Br
Conversion of TBP-1 into TBM-1 and polymerization of TBM-1
TBP-1
S
NN
BrBr
+ MgCl * LiCl
TBM-1
S
NN
BrClMg
THF
30 - 40 % of conversion by NMR method
9 8 7 6 5 4 3 2 1 0Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Inte
ns
ity
16.95 12.002.88 2.120.34
Chloroform-d
S
N N
CH3CH3
CH3CH3
BrH
HCl in dioxane
46
TBP-1
S
NN
BrBr
+ MgCl * LiCl
TBM-1
S
NN
BrClMg
THF
30 - 40 % of conversion by NMR method
PhNidppeBr
S
NN
H
n
TBPol-1
GPC data of TBPol-1
Sample of PTBM-1
Mn (g/mol)
Mw (g/mol)
Mn / Mw
1 400 1200 3.00
2 400 1000 2.50
3 300 900 3.00
4 400 1000 2.50
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
Inte
ns
ity
Chloroform-d
nS
NN
H
Conclusion: Polymerisation proceeds out of order - derangements occur!
NMR spectrum of TBPol-1
Conversion of TBP-1 into TBM-1 and polymerization of TBM-1
47
Conversion of TBP-2 into TBM-2 and polymerization of TBM-2
TBP-2
SSBr Br+ MgCl
THF
SSClMg Br
TBM-2
PhNidppeBr
SS Hn
TBPol-250-60 % conversion by NMR
48
Conversion of TBP-2 into TBM-2
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Inte
ns
ity
30.003.871.88
Chloroform-d
6.9
2
S
S
Br
Br
CH3
CH3
CH3
CH3
7.5 7.4 7.3 7.2 7.1 7.0 6.9 6.8 6.7 6.6 6.5 6.4 6.3 6.2 6.1Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
Inte
ns
ity
2.000.58
Chloroform-d
6.9
2
NMR spectrum of TBP-1
50-60 % conversion by NMR
49
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
Inte
ns
ity
29.564.001.390.22
Chloroform-d
7.3
7
7.5
8
nS SH
CH3
CH3
CH3
CH3
HHH
H
H
H
H
NMR spectrum of TBPol-2
50
NMR spectrum of TBPol-2, field of aromatic proton signals
n = 8
8.1 8.0 7.9 7.8 7.7 7.6 7.5 7.4 7.3 7.2 7.1 7.0 6.9 6.8 6.7 6.6Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
Inte
ns
ity
16.512.232.00 0.75
Chloroform-d
7.3
7
7.5
8
nS SH
CH3
CH3
CH3
CH3
HHH
H
H
H
H
meta- ortho-
β-thiophen protons
β-1
51
GPC data of TBPol-2
Sample of PTBM-2
Mn (g/mol)
Mw (g/mol)
Mn / Mw
1 1500 2300 1.5
2 1200 2200 1.8
Conclusion: Polymerisation proceeds by chain-growth mechanism, but process is not fully controlled.
And so on…
57
V.N. Karazin Kharkiv National University is one of the oldest universities in Eastern Europe. It was founded in November 1804, on the initiative of the prominent educator V.N. Karazin and in accordance with the charter of Tsar Alexander I.
Kharkiv University is the only university in Ukraine that has trained and employed three Nobel Prize laureates: the biologist I. Mechnikov, the economist S. Kuznets, and the physicist L. Landau.
The University of Kharkiv main academic building
The University of Kharkiv main academic building
58
Acronym KKNUAccreditation IVStatus StateEstablished 1804Teaching staff 1300Students trained 15000+
The northern academic building
59
UniversityNumber of Publications in
ScopusNumber of Citation In Scopus Hirsch index (H-index)
Taras ShevchenkoKyiv National University
10947 40807 64
Karazin Kharkiv National University
6072 22974 47
Universities of Ukraine according to Scientometrics database SciVerse Scopus
62
50 Most Innovative CountriesBy Bloomberg Rankings - Feb 1, 2013 11:37 AM GMT-0500
42. UkraineUkraine ranked 42nd in Bloomberg's Global Innovation Index. Here is how the country ranked in the determining factors:
R&D intensity: 37thProductivity: 69thHigh-tech density: 47thResearcher concentration: 39thManufacturing capability: 34thTertiary efficiency: 6thPatent activity: 17th